Method for determining content of medicinal components of Zupa granules with cold asthma based on quantitative analysis of multi-components by single marker

Through one-test and multiple evaluation method combined with high-performance liquid chromatography, the problem of quality control of components in Hanpanzu Pa granule compound was solved, and the simultaneous detection of multiple components was achieved, the experimental steps were simplified, and the determination accuracy and quality control were improved. controllability.

CN118914428APending Publication Date: 2024-11-08XINJIANG MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411241932.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing technology is difficult to fully control the quality of the Hanpanzu Pa granules, especially the single component content measurement in the compound recipe cannot achieve quality control. The traditional method takes a long time and uses organic solvents to pollute the environment. The current standards only carry out quality control for ammonium glycyrrhizate. Others The ingredients quality standards were not promptly proposed.

Method used

Using high-performance liquid chromatography based on one test and multiple evaluations, using nitritein as an internal reference, combined with bonded silica gel chromatography column and gradient elution program, the nitritein, acelerin, and 3'- Simultaneous detection of methoxy apigenin, naringin and glycyrrhizic acid simplifies experimental steps, reduces the use of reference materials, and improves the accuracy of the determination.

Benefits of technology

It realizes efficient quantitative analysis of various components in Hanpanzu Pa granules, simplifies experimental operations, improves the controllability of quality control, makes up for the shortcomings of only measuring a single component ammonium glycyrrhizate in the existing standards, and provides more Comprehensive quality evaluation method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005029547550000071
    Figure BDA0005029547550000071
  • Figure BDA0005029547550000082
    Figure BDA0005029547550000082
  • Figure BDA0005029547550000091
    Figure BDA0005029547550000091
Patent Text Reader

Abstract

The invention provides a method for efficiently detecting active ingredients in Zupa granules for cold asthma based on quantitative analysis of multi-components by single marker. The five active ingredients of aesculetin, apigenin, 3 '-methoxy apigenin, naringenin and glycyrrhizic acid can be simultaneously detected in one chromatographic analysis process. Specifically, the content of aesculetin is analyzed and detected by using high performance liquid chromatography, relative correction factors of other components are calculated by using aesculetin as an internal reference, and the contents of other components in a test solution are respectively calculated. The chromatographic analysis method disclosed by the invention meets the requirements of methodology verification, is simple to operate, high in sensitivity, accurate in determination and strong in applicability, can be used for well and quantitatively analyzing the quality of the cold-asthma Zupa granules, and provides a basis for comprehensively evaluating the quality standard of the medicine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of analysis and detection methods for components of traditional Chinese medicine, and in particular to a method for determining the contents of five active components in Hanchuanzupa granules based on a one-measurement-multiple-evaluation method. Background Art

[0002] Hanchuanzupa Granules are included in the "Uyghur Medicine Volume of Drug Standards of the Ministry of Health of the People's Republic of China". They have the effects of antitussive, expectorant, warming the lungs and relieving asthma. They are mainly used in the treatment of acute colds, coughs caused by cold "Naizilai" and abnormal mucous asthma. They are composed of 9 medicinal materials: Hyssopus officinalis, Adiantum, Licorice extract, Fennel, Celery Seed, Fenugreek, Rue, Rose, and Urtica. At present, the research on Hanchuanzupa Granules is mostly focused on the efficacy and mechanism of action, and there are few reports on the component analysis and content determination of Hanchuanzupa Granules. The commercial preparations and formula granules of Hanchuanzupa Granules are commonly used in clinical practice. Due to the differences in the decoction methods of commercial preparations and formula granules, it is difficult to achieve effective control of the ingredients, which in turn affects the efficacy. Traditional Chinese medicine compound prescriptions often have the characteristics of different components synergizing with each other to exert the efficacy. Therefore, there is a problem that the content determination of a single component in the compound cannot be fully controlled.

[0003] The current quality standard for Hanchuanzupa Granules uses two reference medicinal materials and three reference substances to identify three medicinal materials in the preparation using three thin-layer development systems, namely, rose, licorice and fenugreek in the preparation, which cannot fully control the quality of Hanchuanzupa Granules. In addition, the preparation process of the test solution is complicated and time-consuming, and the three development systems use a lot of organic solvents, which are highly toxic and pollute the environment. The latest "Public Draft of the Revision of the National Drug Standards for Hanchuanzupa Granules" only uses high-performance liquid chromatography (HPLC) to determine the content of ammonium glycyrrhizinate in licorice extract as the quality control indicator of the active ingredient, while the quality standard control of the other 8 medicinal materials has not yet been mentioned.

[0004] In addition to the current quality standards, there are few literature studies related to the quality standards of Hanchuanzupa. Liu Huiying (Liu Huiying, Wang Zhijun, Liu Tianwang. Determination of glycyrrhizic acid content in Hanchuanzupa granules by reversed-phase HPLC [J]. Chinese Journal of Ethnic Medicine, 2007 (03): 40-41) and Wang Guifen (Wang Guifen. Determination of glycyrrhizic acid content in Uyghur patent medicine Hanchuanzupa granules [J]. Chinese Journal of Ethnic Medicine, 2010, 16 (06): 40-41) et al. used reversed-phase HPLC to determine the content of glycyrrhizic acid in Hanchuanzupa granules, but did not analyze and determine the other 8 medicinal materials; Jin Xiao Hong (Jin Xiaohong, Gui Hongwu, Geng Wei. Study on the quality standard of Hanchuanzupa granules [J]. Chinese Pharmacy, 2012, 23(15): 1405-1406) et al. used thin layer chromatography (TLC) to qualitatively identify rose and fennel in Hanchuanzupa granules, and used HPLC to determine the content of ammonium glycyrrhizinate in licorice extract. Hanchuanzupa granules are a compound composed of 9 medicinal materials with complex chemical components. The content determination of a single component may affect its quality control.

[0005] Therefore, it is urgent to develop an efficient and comprehensive content determination and analysis method to achieve a more comprehensive quality control of Hanchuanzupa Granules. Summary of the invention

[0006] The purpose of the present invention is to provide a detection method for determining multiple components in Hanchuanzupa granules.

[0007] In a first aspect of the present invention, a method for simultaneously analyzing multiple components in Hanchuanzupa granules is provided, wherein the multiple components include aesculetin, and two or more selected from the group consisting of apigenin, naringenin, 3'-methoxyapigenin, and glycyrrhizic acid;

[0008] The method comprises the following steps:

[0009] Inject the test solution or reference solution into the HPLC instrument and perform the test using the following HPLC conditions:

[0010] Bonded silica chromatographic columns;

[0011] Mobile phase: Mobile phase A is an aqueous solution containing acetic acid and acetonitrile.

[0012] Mobile phase B was acetonitrile;

[0013] The volume ratio of mobile phase A is concentration A→concentration B→concentration C for gradient elution, wherein concentration A is 90 vol% to 95 vol%, concentration B is 57 vol% to 62 vol%, and concentration C is 90 vol% to 95 vol%;

[0014] The test solution is obtained by subjecting Hanchuanzupa granules to alcohol extraction and filtration.

[0015] In another preferred embodiment, the method further comprises the steps of:

[0016] (1) With aesculetin as the internal reference, according to the formula: fi = (A S ×C R ) / (A R ×C S ) calculation, calculate the relative correction factor fi of apigenin, naringenin, 3'-methoxyapigenin and / or glycyrrhizic acid,

[0017] in,

[0018] fi is the ratio of the absolute correction factor of the reference solution of other components to the reference solution of aesculetin, that is, the relative correction factor.

[0019] C S is the concentration of the esculetin reference solution,

[0020] A S is the detection peak area of ​​the esculetin reference solution,

[0021] C R is the concentration of the reference solution of other ingredients,

[0022] A R is the detection peak area of ​​the reference solution of other components;

[0023] (2) Based on the relative correction factors of aesculetin and apigenin, 3'-methoxyapigenin, naringenin and / or glycyrrhizic acid, combined with the detected aesculetin content, the contents of apigenin, naringenin, 3'-methoxyapigenin and / or glycyrrhizic acid in the test solution were calculated respectively.

[0024] In another preferred embodiment, the bonding group in the bonded silica gel chromatographic column is selected from: C8, C18.

[0025] In another preferred embodiment, the bonded silica gel chromatographic column is an octyl bonded silica gel C18 column.

[0026] In another preferred embodiment, the size of the bonded silica gel chromatographic column is 250 nm×4.6 nm, 5 μm.

[0027] In another preferred embodiment, the bonded silica gel chromatographic column is selected from the following group: Shim-pack VP-ODS chromatographic column, Hypersil BDS C18 chromatographic column.

[0028] In another preferred embodiment, the high performance liquid chromatograph is selected from the following group: LC-20AB-4, 1260Infinity II.

[0029] In another preferred embodiment, in the mobile phase A, the acetic acid is glacial acetic acid.

[0030] In another preferred embodiment, in the mobile phase A, the concentration of acetic acid is 1-5 vol%, and the concentration of acetonitrile is 3-8 vol%. Preferably, the concentration of acetic acid is 2 vol%, and the concentration of acetonitrile is 5.5 vol%.

[0031] In another preferred embodiment, the method performs gradient elution with the volume proportion of mobile phase A being 92 vol%→60 vol%→90 vol%.

[0032] In another preferred embodiment, the duration of the gradient elution is 70 to 90 min, for example 72 min.

[0033] In another preferred embodiment, the gradient elution program is 0-12 min, 92%-90% A; 12-35 min, 90%-87% A; 35-57 min, 87%-79% A; 57-64 min, 70%-60% A; 64-70 min, 60%-90% A; 70-71 min, 90% A.

[0034] In another preferred embodiment, the chromatographic conditions further include an injection volume, and the injection volume is 2-50 μL, preferably 5-20 μL, such as 10 μL.

[0035] In another preferred embodiment, the chromatographic conditions further include a detection wavelength, which is 360-370 nm (0-t1) and 270-290 nm (t1-t2), wherein t1 is 30-40 min, t2 is 70-90 min,

[0036] Preferably, the detection wavelength is 365 nm (0-35 min) and 280 nm (35-72 min).

[0037] In another preferred embodiment, the chromatographic conditions also include a flow rate, and the flow rate is 0.8-1.5 mL / min, preferably 0.8-1.2 mL / min.

[0038] In another preferred embodiment, the chromatographic conditions further include a column temperature, which is 30-45°C, preferably 34-40°C.

[0039] In another preferred embodiment, the relative correction factor of aesculetin and apigenin is 2.2-2.8, such as 2.48 and 2.5.

[0040] In another preferred embodiment, the relative correction factor of aesculetin and 3'-methoxyapigenin is 1.3-1.8, such as 1.5 or 1.7.

[0041] In another preferred embodiment, the relative correction factor of aesculetin and naringenin is 0.7-1.0, such as 0.8 or 0.9.

[0042] In another preferred embodiment, the relative correction factor of aesculetin and glycyrrhizic acid is 24-32, such as 35 or 30.

[0043] In another preferred embodiment, the test solution is prepared by the following method, which comprises:

[0044] s1. Grind the Hanchuanzupa granules, mix with lower alcohol, and perform ultrasonic extraction;

[0045] s2. Filter to obtain the test solution.

[0046] In another preferred embodiment, the lower alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, preferably methanol.

[0047] In another preferred embodiment, the mass volume ratio of the Hanchuanzupa granules to the lower alcohol is 0.1-1 g / mL, preferably 0.4 g / mL.

[0048] In another preferred embodiment, the ultrasonic extraction time is 10-60 min, preferably 20 min.

[0049] In another preferred embodiment, the step s1 further comprises: after ultrasonic extraction, cooling to room temperature, weighing again, and using methanol to make up for the weight lost due to methanol volatilization.

[0050] In another preferred embodiment, the filtration refers to filtration using a 0.22 μm filter membrane.

[0051] In another preferred embodiment, the reference solution is prepared by the following method, which comprises:

[0052] Accurately weigh each ingredient separately, place in a volumetric bottle, and make up to volume with low-grade alcohol.

[0053] In another preferred embodiment, the lower alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, preferably methanol.

[0054] In another preferred embodiment, the mass concentration of apigenin in the apigenin reference solution is 450-500 μg·mL -1 , for example 480 μg·mL -1 .

[0055] In another preferred embodiment, the mass concentration of naringenin in the naringenin reference solution is 450-500 μg·mL -1 , for example 480 μg·mL -1 .

[0056] In another preferred embodiment, the mass concentration of aesculetin in the aesculetin reference solution is 450-500 μg·mL -1 , for example 480 μg·mL -1 .

[0057] In another preferred embodiment, the mass concentration of 3'-methoxy celery glycoside in the 3'-methoxy celery glycoside reference solution is 1500-2000 μg·mL -1 , for example 1600 μg·mL -1 .

[0058] In another preferred embodiment, the mass concentration of glycyrrhizic acid in the glycyrrhizic acid reference solution is 4.50-5 μg·mL -1 , for example 4.8 μg·mL -1 .

[0059] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS

[0060] Figure 1 The chromatogram of the mixed reference solution is shown. (Note: 1: aesculin, 2: apigenin, 3: 3'-methoxyapigenin, 4: naringenin, 5: glycyrrhizic acid)

[0061] Figure 2 The chromatogram of the test solution of Hanchuanzupa granules is shown. (Note: 1: aesculin, 2: apigenin, 3: 3'-methoxyapigenin, 4: naringenin, 5: glycyrrhizic acid) DETAILED DESCRIPTION

[0062] After extensive and in-depth research, the inventors have discovered for the first time a method for efficiently detecting active ingredients in Hanchuanzupa granules based on "one test and multiple evaluations", which can simultaneously detect five active ingredients of fraxinoside, apigenin, 3'-methoxyapigenin, naringenin, and glycyrrhizic acid in one chromatographic analysis process. The chromatographic analysis method of the present invention has a large linear range, meets the requirements of methodological validation, is simple to operate, has high sensitivity, accurate determination, and strong applicability. It can well perform quantitative analysis on the quality of Hanchuanzupa granules, and provide a basis for comprehensively evaluating the quality standards of the drug.

[0063] the term

[0064] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0065] As used herein, the terms "comprise", "include", and "contain" are used interchangeably and include not only closed definitions, but also semi-closed and open definitions. In other words, the terms include "consisting of", "consisting essentially of".

[0066] As used herein, when used in reference to a specific recited numerical value, the term "about" means that the value may vary by no more than 1% from the recited value. For example, as used herein, the expression "about 100" includes all values ​​between 99 and 101 (e.g., 99.1, 99.2, 99.3, 99.4, etc.).

[0067] Method of the present invention

[0068] The present invention provides a method for determining the content of components of Hanchuanzupa granules based on a one-measurement-multiple-evaluation method, wherein aesculetin is used as an internal reference for one-measurement-multiple-evaluation, relative correction factors of aesculetin and apigenin, vitexin, 3'-methoxyapigenin, and glycyrrhizic acid are established, and the content of components in Hanchuanzupa granules is calculated by the relative correction factors, which specifically comprises the following steps:

[0069] [Preparation of test solution]: Take 2g of Hanchuanzupa granule powder, grind it into powder, add 5mL of methanol, weigh it, perform ultrasonic extraction for 20min, cool it to room temperature, weigh it again, make up the lost weight with methanol, shake it well, filter it, and pass it through a 0.22μm filter membrane to obtain the test solution.

[0070] [Preparation of reference solution]: Accurately weigh an appropriate amount of reference solution, place in a volumetric bottle, and dilute with methanol. The mass concentration is 480 μg mL -1 、naringenin 480μg·mL -1 , Fraxin 480 μg·mL -1 、3'-methoxyapigenin 1600μg·mL -1 , glycyrrhizic acid 4.8 mg·mL -1 , filter through a microporous membrane to obtain the product.

[0071] [Preparation of 5 mixed reference solutions]: Take the above 5 reference solutions separately, mix them and dilute them into 6 different mass concentrations, store them at 4℃ for later use.

[0072] [HPLC conditions]: A Hypersil BDS C18 column (250 nm × 4.6 nm, 5 μm) was used; mobile phase A: water (containing 2% acetic acid and 5.5% acetonitrile); mobile phase B: acetonitrile; gradient elution program: 0-12 min, 92%-90% A; 12-35 min, 90%-87% A; 35-57 min, 87%-79% A; 57-64 min, 70%-60% A; 64-70 min, 60%-90% A; 70-71 min, 90% A; detection wavelength: 365 nm (0-35 min), 280 nm (35-72 min); injection volume: 10 μL; flow rate: 1.0 mL min -1 , column temperature: 37℃.

[0073] [High performance liquid chromatography determination]: The reference solution was placed in a high performance liquid chromatograph and tested under the above-mentioned high performance liquid chromatography conditions; with aesculetin as the internal reference, according to the formula: fi = (A S ×C R ) / (A R ×C S ), where fi is the ratio of the absolute correction factor of other reference substances to that of the esculetin reference substance, i.e., the relative correction factor, C S is the concentration of esculetin reference substance, A S is the peak area of ​​esculetin reference substance, C R is the concentration of the component to be measured, A R The relative correction factors fi of apigenin, naringenin, 3'-methoxy apigenin and glycyrrhizic acid were calculated as the peak area of ​​the components to be tested; the test solution and the mixed reference solution were respectively injected into the high performance liquid chromatograph for detection under the above chromatographic conditions to determine the content of aesculetin in Hanchuanzupa granules, and then the contents of apigenin, naringenin, 3'-methoxy apigenin and glycyrrhizic acid in Hanchuanzupa granules were calculated according to the relative correction factors of aesculetin and apigenin, 3'-methoxy apigenin, naringenin and glycyrrhizic acid. The relative correction factors of aesculetin and apigenin, 3'-methoxy apigenin, naringenin and glycyrrhizic acid were 2.48, 1.50, 0.80 and 30.99, respectively.

[0074] The "one test, multiple evaluations" method was first proposed by Wang Zhimin and others from the China Academy of Chinese Medical Sciences in 2006. This method uses a relatively easy-to-obtain and inexpensive internal reference material to achieve simultaneous determination of the contents of multiple components. It has the characteristics of simple operation, accurate and comprehensive determination, and solves the problems of difficult management of Chinese medicine compound preparations and expensive reference materials. It is currently widely used in the quality control of Chinese medicine compound preparations. This experiment used quinoline, apigenin, vitexin, 3'-methoxyapigenin, and glycyrrhizic acid to establish a one-test, multiple evaluation analysis method based on HPLC, and analyzed it according to the standard, laying the foundation for the research and development and quality standards of Hanchuanzupa Granules.

[0075] The main advantages of the present invention include:

[0076] 1. For the first time, a "one-test, multiple-evaluation" HPLC content determination analysis method for Hanchuanzupa Granules was created. The test sample and control solution were obtained by a simple and quick pretreatment method, and five components common to multiple medicinal materials in Hanchuanzupa Granules were detected simultaneously under the same chromatographic conditions, including glycyrrhizic acid, a pentacyclic triterpenoid component, three flavonoid components (apigenin, naringenin, 3'-methoxyapigenin) and one coumarin component (fraxinoyl ester). A total of five components are indicators for the one-test, multiple-evaluation method for content determination of Hanchuanzupa Granules, which can achieve more efficient and comprehensive quality control, making up for the deficiency of the "Draft for Publicity of the Revision of the National Drug Standards for Hanchuanzupa Granules" that only determines the content of a single component, ammonium glycyrrhizinate.

[0077] 2. Using water (containing 2% glacial acetic acid and 5.5% acetonitrile) and acetonitrile as mobile phases, a C18 chromatographic column (250nm×4.6nm, 5μm) was used to determine the contents of 5 common components in 9 medicinal materials in Hanchuanzupa Granules under the same chromatographic conditions, and relative correction factors of the other four components were calculated using quinoline as an internal reference. This can achieve simultaneous qualitative identification and quantitative determination of multiple components in multiple medicinal materials, and avoid the possibility of adulteration by adding a known component.

[0078] 3. The method established by the present invention is simple and quick to operate. Only 2g of Hanchuanzupa granules and one reference substance are needed, and multiple components can be simultaneously determined using only one reference substance. Compared with other methods, this method simplifies the experimental operation steps, saves experimental consumables, uses less reference substances, has high accuracy, and measures the amounts of multiple index components in Hanchuanzupa granules, thereby ensuring the controllability of the quality of the preparation.

[0079] 4. The HPLC one-test-multiple-evaluation content determination method for Hanchuanzupa granules established in the present invention has good analytical and evaluation capabilities, and has the advantages of being accurate, simple, stable and reliable. Therefore, this method can be used as an effective evaluation method for this prescription.

[0080] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods for the unrecorded specific conditions in the following examples are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are weight percentages and weight parts.

[0081] Example

[0082] 1. Instruments and Reagents

[0083] 1.1 Instrument

[0084] High performance liquid chromatograph (LC-20AB-4 high performance liquid chromatograph (Shimadzu Corporation, Japan) and 1260 Infinity II high performance liquid chromatograph (Agilent), desktop high power digital display ultrasonic instrument (KQ-200KDE, Kunshan Ultrasonic Instrument Co., Ltd.), Shim-pack VP-ODS chromatographic column (250 mm × 4.6 mm, 5 μm), Hypersil BDS C18 chromatographic column (250 mm × 4.6 mm, 5 μm); analytical balance (ME204E, 1 / 10,000, Mettler-Toledo Instrument Shanghai Co., Ltd.).

[0085] 1.2 Reagents

[0086] Apigenin (batch number wkq22070406), esculentin (batch number wkq22041512), naringenin (batch number wkq23010507), and 3'-methoxyapigenin (batch number wkq23020308) were purchased from Sichuan Weikeqi Biotechnology Co., Ltd. Glycyrrhizic acid (batch number RDD-G00402112016) and vitexin (batch number RDD-M02302002022) were purchased from Beijing Yingke Technology Co., Ltd. Licorice glycoside (China Food and Drug Biological Products Control Institute); 3 batches of commercial preparations of Hanchuanzupa granules, licorice extract (batch number 20191204), rose (batch number 20191009-10 4), fenugreek (batch number 20191025-111), celery seed (batch number 20191001-113), hyssop (batch number 20190802-095), maidenhair fern (batch number 20190925-098), nettle seed (batch number 20201229-001), rue (batch number 20200617-026), fennel (batch number 20190814-106) were purchased from Xinqikang Pharmaceutical Co., Ltd.; methanol (analytical grade, Tianjin Zhiyuan Chemical Reagent Co., Ltd.), phosphoric acid (superior grade, Chengdu Kelon Chemical Reagent Factory), glacial acetic acid (Tianjin Fuchen Chemical Reagent Factory), chromatographic methanol, acetonitrile.

[0087] 2. Methods and Results

[0088] 2.1 Chromatographic conditions

[0089] HPLC conditions: Hypersil BDS C18 column (250 nm × 4.6 nm, 5 μm), mobile phase A: water (containing 2% acetic acid and 5.5% acetonitrile), mobile phase B: acetonitrile; gradient elution program: 0-12 min, 92%-90% A; 12-35 min, 90%-87% A; 35-57 min, 87%-79% A; 57-64 min, 70%-60% A; 64-70 min, 60%-90% A; 70-71 min, 90% A, detection wavelength: 365 nm (0-35 min), 280 nm (35-72 min); injection volume: 10 μL; flow rate: 1.0 mL min -1 , column temperature: 37℃.

[0090] 2.2 Preparation of test solution

[0091] Take 2g of Hanchuanzupa granule powder, grind it into powder, add 5mL of methanol, weigh it, perform ultrasonic extraction for 20min, cool it to room temperature, weigh it again, make up the lost weight with methanol, shake it well, and filter it through a 0.22μm filter membrane.

[0092] 2.3 Preparation of mixed reference solution

[0093] Accurately weigh an appropriate amount of reference substance, place it in a volumetric flask, and adjust the volume with methanol to obtain a mass concentration of 480 μg mL of apigenin. -1 、naringenin 480μg·mL -1 , Fraxin 480 μg·mL -1 、3'-methoxyapigenin 1600μg·mL -1 , glycyrrhizic acid 4.8 mg·mL -1 , and filter through a microporous membrane. Take the above 5 reference solutions respectively, mix them and dilute them into 6 different mass concentrations, store them at 4℃ for later use.

[0094] 2.4 Methodological Review

[0095] 2.4.1 Chromatographic conditions and system suitability test

[0096] The test sample and the mixed reference solution were respectively placed into the HPLC and tested under the above HPLC conditions; the mixed reference solution ( Figure 1 ) and test solution ( Figure 2 ) was injected into a liquid chromatograph, and the results showed that the separation degree of each chromatographic peak was greater than 1.5, and the number of theoretical plates was greater than 30,000.

[0097] 2.4.2 Linearity and range

[0098] Accurately pipette 10 μL of each of the six mixed reference solutions of different mass concentrations under item "2.3", and determine according to the chromatographic conditions under item "2.1". With the mass concentration of the reference as the abscissa (X) and the peak area as the ordinate (Y), draw the standard curves of quercetin, apigenin, 3'-methoxyapigenin, naringenin, and glycyrrhizic acid, and obtain the linear regression equation. The results show that the five components have a good linear relationship within the corresponding mass concentration range. The results are listed in Table 1.

[0099] Table 1 Linear regression equations of the five active ingredients of Hanchuanzupa granules

[0100]

[0101]

[0102] 2.4.3 Precision experiment

[0103] Intra-day precision: 10 μL of the prepared high, medium and low concentration reference solution was accurately aspirated, and the sample was injected 6 times continuously according to the chromatographic conditions to determine the area of ​​each chromatographic peak and calculate the RSD value of the chromatographic peak area. The high concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin and glycyrrhizic acid were 0.76%, 0.70%, 0.89%, 0.70% and 1.23% respectively; the medium concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin and glycyrrhizic acid were 0.86%, 0.73%, 0.83%, 0.75% and 0.82% respectively; the low concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin and glycyrrhizic acid were 1.23%, 1.12%, 1.35%, 1.23% and 0.99% respectively. It shows that the intra-day precision of the instrument is good.

[0104] Inter-day precision: 10 μL of the prepared high, medium and low concentration reference solution was accurately aspirated, and the samples were injected continuously for 3 days according to the chromatographic conditions, twice a day, and the area of ​​each chromatographic peak was determined, and the RSD value of the chromatographic peak area was calculated. The high concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin, and glycyrrhizic acid was 4.84%, 5.31%, 4.79%, 4.28%, and 6.51%, respectively; the medium concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin, and glycyrrhizic acid was 2.37%, 2.78%, 2.46%, 2.31%, and 3.62%, respectively; the low concentration of esculetin, apigenin, 3'-methoxy apigenin, naringenin, and glycyrrhizic acid was 2.76%, 3.16%, 3.03%, 3.99%, and 1.43%, respectively.

[0105] 2.4.4 Sample stability test

[0106] Take the test solution prepared under "2.2" and measure it under the chromatographic conditions under "2.1" at 0, 2, 4, 8, 12, and 24 hours. Record the peak areas of the five components in the test solution at each time point, and calculate the RSD values ​​of apigenin, apigenin, 3'-methoxyapigenin, naringenin, and glycyrrhizic acid. The results are shown in Table 2, indicating that the test solution is relatively stable within 24 hours.

[0107] Table 2 Stability test results of the test solution within 24 hours

[0108]

[0109]

[0110] 2.4.5 Repeatability Experiment

[0111] Six test sample solutions were prepared in parallel according to the method under "2.2" and measured six times under the chromatographic conditions under "2.1". The RSDs of the peak areas of quercetin, apigenin, 3'-methoxyapigenin, naringenin and glycyrrhizic acid were 2.66%, 2.65%, 3.78%, 3.83% and 3.63%, respectively, indicating that the method had good repeatability.

[0112] 2.4.6 Sample recovery experiment

[0113] According to the method under "2.2", 6 test solutions of the same batch of Hanchuanzupa granules were prepared in parallel, and each reference solution was added according to the content of the test sample-reference substance content (1:1). The determination was carried out under the chromatographic conditions under "2.1". The average sample recovery and RSD of quinoline, apigenin, 3'-methoxyapigenin, naringenin and glycyrrhizic acid were calculated to meet the recovery limit requirements. The average sample recovery results were 98.7%, 100.3%, 100.1%, 100.2%, and 100.0%, respectively, and the RSD values ​​were 2.62%, 1.61%, 1.89%, 2.30%, and 0.91%, respectively. The results are shown in Table 3 below, indicating that the accuracy of the method is good.

[0114] Table 3 Results of sample recovery of reference substances in Hanchuanzupa granules

[0115]

[0116]

[0117] 2.5 Determination of relative correction factor

[0118] Mix the reference solution in series of concentrations under "2.3" and determine under the chromatographic conditions under "2.1", taking aesculetin as the internal reference, according to the formula: fi = (A S ×C R) / (A R ×C S ) is calculated. Where: fi is the ratio of the absolute correction factor of other reference substances to the reference substance of aesculetin, that is, the relative correction factor, C S is the concentration of esculetin reference substance, A S is the peak area of ​​esculetin reference substance, C R is the concentration of the component to be tested, A R The relative correction factor fi of other reference substances is calculated by taking the peak area of ​​the component to be tested. The results are shown in Table 4.

[0119] Table 4 Calculation results of relative correction factors

[0120]

[0121]

[0122] 2.6 Durability study of relative correction factor

[0123] 2.6.1 Effects of different chromatographic columns and instruments on relative correction factors

[0124] The mixed reference solution was prepared according to item "2.3". According to the chromatographic conditions under item "2.1", two different types of high performance liquid chromatographs, LC-20AB-4 (Shimadzu Corporation, Japan) and 1260 Infinity II (Agilent Technologies, USA), two different brands of chromatographic columns, Shim-pack VP-ODS column (250 mm × 4.6 mm, 5 μm) and Hypersil BDS C18 column (250 nm × 4.6 nm, 5 μm), were used respectively. Fraxinus acetylcholine was used as the internal reference. The effects on the relative correction factors of the components to be tested are listed in Tables 5 and 6.

[0125] The results showed that apigenin, 3'-methoxyapigenin, naringenin, glycyrrhizic acid and internal reference aesculetin had good reproducibility under different instruments and chromatographic columns, with RSDs ranging from 0.05% to 3.58%.

[0126] Table 5 Effects of different instruments on f i Impact of (n=3)

[0127]

[0128] Table 6 Effect of different chromatographic columns on f i Impact of (n=3)

[0129]

[0130] 2.6.2 Effect of different column temperatures on f s / i Impact

[0131] Prepare the mixed reference solution according to item "2.3" and analyze it using 1260 InfinityII (Agilent) HPLC according to the chromatographic conditions in item "2.1". Take aesculetin as the internal reference and determine and calculate the f of each component with RA under different column temperatures (34, 37, 40°C). s / i , and RSD was calculated. The results are shown in Table 7, which showed that the relative correction factors between apigenin, 3'-methoxyapigenin, naringenin, glycyrrhizic acid and the internal reference substance aesculetin at different column temperatures were well applicable.

[0132] Table 7 Effect of different column temperatures on f i Impact of (n=3)

[0133]

[0134]

[0135] 2.6.3 Effect of different flow rates on f s / i Impact

[0136] Prepare the mixed reference solution according to item "2.3" and use 1260 InfinityII (Agilent) HPLC and Shim-pack VP-BDS column according to the chromatographic conditions in item "2.1" to measure the f of each component with RA under different volume flow conditions (0.9, 1.0, 1.1 mL / min) with aesculetin as the internal reference. s / i The results showed (Table 8) that the relative calibration factors between apigenin, 3'-methoxyapigenin, naringenin, glycyrrhizic acid and the internal reference substance aesculetin at different column temperatures were well applicable.

[0137] Table 8 Effect of different flow rates on f i Impact of (n=3)

[0138]

[0139] 2.6.4 Positioning of chromatographic peaks of components to be measured

[0140] The relative value of the retention time of quinoline was selected as the positioning standard for the component to be measured, and the relative retention times of different high performance liquid chromatographs and different chromatographic columns were calculated. The results are listed in Tables 9 and 10.

[0141] The results showed that under different instrumental conditions, the RSDs of the relative retention times of glycyrrhizic acid, apigenin, 3'-methoxyapigenin, naringenin and the internal reference substance aesculetin were 1.17%, 2.00%, 2.39% and 2.46%, respectively. The mean values ​​of the relative retention times of the components on different chromatographic columns and the internal reference substance aesculetin were 3.85, 3.33, 10.76 and 14.00%, respectively, indicating that it is feasible to quantify the target substances by relative retention time.

[0142] Table 9 Relative retention time of different instruments

[0143]

[0144] Table 10 Relative retention time of different chromatographic columns

[0145]

[0146]

[0147] 2.7 Determination of key components in Hanchuanzupa granules

[0148] Hanchuanzupa granules from three different manufacturers were taken and tested according to the sample processing method under "2.2" and the chromatographic conditions under "2.1", and the results are listed in Table 11. The test results show that the contents of the five target components in Hanchuanzupa granules from different batches / manufacturers vary greatly, further indicating that the experimental scheme of the present invention can achieve comprehensive analysis and determination of Hanchuanzupa granules, thereby achieving effective quality control.

[0149] Table 11 Contents of five main components in Hanchuanzupa granules produced by different manufacturers

[0150]

[0151] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.

Claims

1. A method for simultaneously analyzing multiple components in Hanchuanzupa granules, wherein: The multiple ingredients include aesculetin, and two or more selected from the group consisting of apigenin, naringenin, 3'-methoxyapigenin, and glycyrrhizic acid; The method comprises the following steps: Inject the test solution or reference solution into the HPLC instrument and perform the test using the following HPLC conditions: Bonded silica chromatographic columns; Mobile phase: Mobile phase A is an aqueous solution containing acetic acid and acetonitrile. Mobile phase B was acetonitrile; The volume ratio of mobile phase A is concentration A→concentration B→concentration C for gradient elution, wherein concentration A is 90 vol% to 95 vol%, concentration B is 57 vol% to 62 vol%, and concentration C is 90 vol% to 95 vol%; The test solution is obtained by subjecting Hanchuanzupa granules to alcohol extraction and filtration.

2. The method according to claim 1, characterized in that The method further comprises the steps of: (1) With aesculetin as the internal reference, according to the formula: fi = (A S ×C R ) / (A R ×C S ) calculation, calculate the relative correction factor fi of apigenin, naringenin, 3'-methoxyapigenin and / or glycyrrhizic acid, in, fi is the ratio of the absolute correction factor of the reference solution of other components to the reference solution of aesculetin, that is, the relative correction factor. C S is the concentration of the esculetin reference solution, A S is the detection peak area of ​​the esculetin reference solution, C R is the concentration of the reference solution of other ingredients, A R is the detection peak area of ​​the reference solution of other components; (2) Based on the relative correction factors of aesculetin and apigenin, 3'-methoxyapigenin, naringenin and / or glycyrrhizic acid, combined with the detected aesculetin content, the contents of apigenin, naringenin, 3'-methoxyapigenin and / or glycyrrhizic acid in the test solution were calculated respectively.

3. The method according to claim 1, characterized in that The bonded silica gel chromatographic column is an octyl bonded silica gel C18 column.

4. The method according to claim 1, characterized in that In the mobile phase A, the concentration of acetic acid is 1-5 vol%, and the concentration of acetonitrile is 3-8 vol%. Preferably, the concentration of acetic acid is 2 vol%, and the concentration of acetonitrile is 5.5 vol%.

5. The method according to claim 1, characterized in that The chromatographic conditions also have one or more of the following characteristics: (1) The chromatographic conditions also include an injection volume of 2-50 μL, preferably 5-20 μL; (2) The chromatographic conditions also include a detection wavelength, which is 360-370 nm (0-t1) and 270-290 nm (t1-t2), wherein t1 is 30-40 min and t2 is 70-90 min. Preferably, the detection wavelength is 365 nm (0-35 min) and 280 nm (35-72 min); (3) The chromatographic conditions also include a flow rate of 0.8-1.5 mL / min, preferably 0.8-1.2 mL / min; (4) The chromatographic conditions also include column temperature, which is 30-45°C, preferably 34-40°C.

6. The method according to claim 1, characterized in that The relative correction factors of aesculetin and apigenin were 2.2-2.8; The relative correction factors of aesculetin and 3′-methoxyapigenin were 1.3–1.8; The relative correction factors of esculetin and naringenin were 0.7-1.0; The relative correction factors of aesculetin and glycyrrhizic acid were 24-32.

7. The method according to claim 1, characterized in that The test solution is prepared by the following method, which comprises: s1. Grind the Hanchuanzupa granules, mix with lower alcohol, and perform ultrasonic extraction; s2. Filter to obtain the test solution.

8. The method according to claim 1, characterized in that The reference substance solution is prepared by the following method, which comprises: Accurately weigh each ingredient separately, place in a volumetric bottle, and make up to volume with low-grade alcohol.

9. The method according to claim 7 or 8, characterized in that The lower alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol, preferably methanol.

10. The method according to claim 7, characterized in that The ultrasonic extraction time is 10-60 min, preferably 20 min.